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Introduction:
Cancer cells can generate their own signals in order to sustain their growth and survival. Several studies have revealed the role of
cancer derived-exosomes in activating signal transduction pathways involved in cancer cell proliferation and survival. Chronic
myeloid leukaemia (CML) is a myeloproliferative disorder characterized by the expression of the chimeric BCR-ABL oncoprotein
with constitutive tyrosine kinase activity. We have previously shown that chronic myeloid leukaemia cells released exosomes able to
affect tumour microenvironment.
Methods:
Cell lines used in experiments are LAMA84, a human CML cell line. MTT assay was performed after LAMA84 serum deprivation
and up to 1 week of exosomes treatment; colony formation assay was performed in methylcellulose to assess the capabilities of CML-
derived exosomes to promote the formation of LAMA84-colonies. NOD-SCID mice were subcutaneously injected with LAMA84
cells and exosomes inoculation was performed in tumour site, twice a week; tumour growth was measured and tumours were
removed to extract RNA. RNA was extracted from LAMA84 cells, colonies and mice biopsies. Quantitative gene expression analysis
for pro- and anti- apoptotic genes was performed by TaqMan RT-PCR.
Results:
CML cells, exposed to serum deprivation and treated, up to one week, with exosomes, result in a growth advantage. Moreover,
exosomes treatment promotes the formation of LAMA84 colonies in methylcellulose. In vivo experiments show a greater increase in
tumour size in mice treated with exosomes, compared to control. Real time PCR analyses, performed after RNA extraction from both
in vitro and in vivo samples, show an increase of mRNA levels of anti-apoptotic genes, such us bcl-w, bcl-xl and survivin and a
reduction of pro-apoptotic genes, bad, bax and puma. 
Summary/Conclusion:
Chronic myeloid leukaemia derived-exosomes promote, through an autocrine mechanism, the proliferation and survival of tumour
cells, both in vitro and in vivo, by activation of anti-apoptotic pathways.
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